Total Clarity Wealth Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Total Clarity Wealth Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-250	Closed	-$4K	–	1086
2021 Q3	$4K	Buy	+250	New	+$2.92K	﹤0.01%	878
2021 Q2	–	Sell	-7,850	Closed	-$84K	–	824
2021 Q1	$84K	Buy	+7,850	New	+$97.1K	0.05%	267

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Total Clarity Wealth Management's TRIL Position: Q4 2021 in Review

Total Clarity Wealth Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 250 shares — an estimated $4K sold.

Total Clarity Wealth Management first reported a position in TRIL in Q1 2021 and held it in 2 quarters. The position peaked at $84K in Q1 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Total Clarity Wealth Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Total Clarity Wealth Management sold 250 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $4K.
Total Clarity Wealth Management first reported a position in Trillium Therapeutics Inc. in Q1 2021 and held it in 2 quarters.
Total Clarity Wealth Management's Trillium Therapeutics Inc. position peaked at $84K in Q1 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Total Clarity Wealth Management's 13F filing for Q4 2021, filed 3 Feb 2022.